Inflammation-triggering Engineered Macrophages (MacTriggers) Are Promising Cell-based Therapeutic Avenues for Chemoresistant Solid Tumors
MacTriggers offer a novel, effective, and safer therapeutic approach for chemoresistant solid tumors, addressing chemotherapy limitations and improving outcomes in drug-resistant cancers.
Authors
- Takeshi Mori (ORCID: https://orcid.org/0000-0002-1821-5427)
- Yoshiki Katayama (ORCID: https://orcid.org/0000-0002-4957-6241)
- Shoichi Hijii
- Tatsuhiro Ishida (ORCID: https://orcid.org/0000-0002-1333-6465)
- Kenta Tanito
- Haruka Takata (ORCID: https://orcid.org/0000-0001-7792-2239)
- Akihiro Kishimura (ORCID: https://orcid.org/0000-0002-0503-1418)
- Toma Yoshimi
- Teruki Nii (ORCID: https://orcid.org/0000-0002-8269-8021)
Institutions
- Kyushu University (JP)
- Tokushima University (JP)
Publication Details
- Journal
- Anticancer Research
- Published
- 2025-03-28
- DOI
- https://doi.org/10.21873/anticanres.17525
- Primary Topic
- Phagocytosis and Immune Regulation
- Type
- article
- Field-Weighted Citation Impact
- 0.00